Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 4407-4412, October 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spyrou, G.
Right arrow Articles by Holmgren, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spyrou, G.
Right arrow Articles by Holmgren, A.

Selenite and Selenate Inhibit Human Lymphocyte Growth via Different Mechanisms1

Giannis Spyrou2, Mikael Björnstedt, Sven Skog and Arne Holmgren

The Medical Nobel Institute for Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 77 Stockholm [G. S., M. B., A. H.]; Department of Bioscience, Center for Biotechnology, Karolinska Institutet, Novum. S-141 57 Huddinge [G. S.]; and Department of Medical Radiobiology, Karolinska Institutet, S-171 76 Stockholm [S. S.], Sweden

Selenium compounds like selenite and selenate have strong inhibitory effects, particularly on mammalian tumor cell growth by unknown mechanisms. We found that the addition of sodium selenite and sodium selenate inhibited the growth of human 3B6 and BL41 lymphocytes. Selenite was more potent because 10 µM selenite produced a growth inhibitory effect similar to that of 250 µM selenate. The mechanism of action of selenite and selenate appears to be different. 3B6 and BL41 cells treated with selenite accumulated in the S-phase; however, selenate caused an accumulation of cells in G2. Selenite-mediated growth inhibition was irreversible, although the effects of selenate could be reversed. Selenite, in contrast to selenate, is efficiently reduced by the thioredoxin system (thioredoxin, thioredoxin reductase, and NADPH). At concentrations required to observe a similar effect on cell growth, the activity of thioredoxin reductase, recently shown to be a selenoprotein, increased in selenite-treated cells and decreased in selenate-treated cells. Ribonucleotide reductase activity was inhibited in an in vitro assay by selenite and selenodiglutathione but not by selenate. These results show that selenite and selenate use different mechanisms to inhibit cell growth.

1 This work was supported by grants from the Swedish Medical Research Council (Projects 13X-10370, 13P-10636, and 13X-3529), the Swedish Cancer Society (961), and the Karolinska Institute.

2 To whom requests for reprints should be addressed, at Department of Bioscience, Center for Biotechnology, Karolinska Institutet, Novum, S-141 57 Huddinge, Sweden. Phone: 46-8-608-91-62; Fax: 46-8-74-55-38; E-mail: Giannis.Spyrou@mbb.ki.se.

Received 2/12/96. Accepted 8/ 1/96.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
L. Bjorkhem-Bergman, U.-B. Torndal, S. Eken, C. Nystrom, A. Capitanio, E. H. Larsen, M. Bjornstedt, and L. C. Eriksson
Selenium prevents tumor development in a rat model for chemical carcinogenesis
Carcinogenesis, January 1, 2005; 26(1): 125 - 131.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Nalvarte, A. E. Damdimopoulos, C. Nystom, T. Nordman, A. Miranda-Vizuete, J. M. Olsson, L. Eriksson, M. Bjornstedt, E. S. J. Arner, and G. Spyrou
Overexpression of Enzymatically Active Human Cytosolic and Mitochondrial Thioredoxin Reductase in HEK-293 Cells: EFFECT ON CELL GROWTH AND DIFFERENTIATION
J. Biol. Chem., December 24, 2004; 279(52): 54510 - 54517.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
N. V. Gopee, V. J. Johnson, and R. P. Sharma
Sodium Selenite-Induced Apoptosis in Murine B-Lymphoma Cells Is Associated with Inhibition of Protein Kinase C-{delta}, Nuclear Factor {kappa}B, and Inhibitor of Apoptosis Protein
Toxicol. Sci., April 1, 2004; 78(2): 204 - 214.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C.-L. Shen, W. Song, and B. C. Pence
Interactions of Selenium Compounds with Other Antioxidants in DNA Damage and Apoptosis in Human Normal Keratinocytes
Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 385 - 390.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
E. R. Hofman, M. Boyanapalli, D. J. Lindner, X. Weihua, B. A. Hassel, R. Jagus, P. L. Gutierrez, and D. V. Kalvakolanu
Thioredoxin Reductase Mediates Cell Death Effects of the Combination of Beta Interferon and Retinoic Acid
Mol. Cell. Biol., November 1, 1998; 18(11): 6493 - 6504.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S.-O. Yoon, M.-M. Kim, and A.-S. Chung
Inhibitory Effect of Selenite on Invasion of HT1080 Tumor Cells
J. Biol. Chem., June 1, 2001; 276(23): 20085 - 20092.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.